Clinical Trials Logo

Clinical Trial Summary

This study is designed to investigate the efficacy and safety of capecitabine versus vinorelbine as a postoperative adjuvant chemotherapy, for high risk breast cancer patients who have pathologic residual cancer cells after the preoperative chemotherapy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03703427
Study type Interventional
Source Shandong Cancer Hospital and Institute
Contact
Status Not yet recruiting
Phase Phase 2
Start date November 2018
Completion date November 2025